Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.
Haystack Oncology enables precision oncology to optimize treatment strategies.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.
Bayesian Health is an adaptive AI platform that offers health systems through clinical AI.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Catalio Capital Management has invested in 139 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Life Science, Medical, Therapeutics. The firm invests across 25 different industry categories.
Among tracked funding rounds, Parabilis Medicines received $305.0M in a Series F round. Catalio Capital Management's total known invested capital is $11.4B.
Catalio Capital Management's average investment size is $82.0M across its portfolio of 139 companies.
Recent Catalio Capital Management portfolio additions include Septerna, Perceive Biotherapeutics, Metagenomi, Thrive Earlier Detection, Sherlock Biosciences. These companies were founded in 2020 or later.